111 – 120 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society
(
- Contribution to journal › Article
-
Mark
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
(
- Contribution to journal › Article
-
Mark
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
-
Mark
A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space
(
- Contribution to journal › Article
-
Mark
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
(
- Contribution to journal › Article
-
Mark
IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells
(
- Contribution to journal › Article
- 1998
-
Mark
Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma
(
- Contribution to journal › Article
-
Mark
Corticosteroides
(
- Contribution to journal › Article
-
Mark
High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack
(
- Contribution to journal › Article